4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Supernus Pharmaceuticals, Inc. (SUPN) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Rockville, United States with about 778 employees. Its market capitalization is roughly $3 billion. In the fiscal year ended 2025-12-31, SUPN reported $719M in revenue and ($38M) in net income.
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States.
Interactive charts & full statements → Open the SUPN valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $719M | $662M | $608M | $667M | — |
| Gross Profit | $644M | $584M | $524M | $580M | — |
| Operating Income (EBIT) | ($37M) | $76M | $13M | $46M | — |
| Net Income | ($38M) | $74M | $1M | $61M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $208M | $212M | $192M | $166M | $150M | — |
| Gross Profit | $184M | $189M | $173M | $149M | $134M | — |
| Operating Income (EBIT) | ($6M) | $14M | ($60M) | $12M | ($3M) | — |
| Net Income | ($2M) | ($4M) | ($45M) | $22M | ($12M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $1.5B | $1.4B | $1.3B | $1.7B | — |
| Total Liabilities | $391M | $332M | $356M | $816M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SUPN viewer.
About TickerBase · Data methodology & sources